Skip to main content
. 2021 Jun 28;13(13):3218. doi: 10.3390/cancers13133218

Figure 2.

Figure 2

ROC chart. (A) Survival of cervical adenocarcinoma predicted by PIK3CA mutation status as detected in circulating DNA collected before treatment. (B) Survival of cervical adenocarcinoma predicted by PIK3CA mutation status as detected in circulating DNA collected during follow-up after treatment. (C) Recurrence of cervical adenocarcinoma predicted by PIK3CA mutation status as detected in circulating DNA collected during follow-up after treatment.